Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

U.S. Personal Products Industry Analysis

UpdatedSep 02, 2026
DataAggregated Company Financials
Companies107
  • 7D-3.2%
  • 3M20.3%
  • 1Y-8.1%
  • YTD1.4%

Over the last 7 days, the Personal Products industry has dropped 3.2%, driven by Estée Lauder Companies declining 4.6%. Meanwhile, Coty actually outperformed within the industry, gaining 6.4% in the last week. The industry has fallen 8.1% in the last year. As for the next few years, earnings are expected to grow by 27% per annum.

Industry Valuation and Performance

Has the U.S. Personal Products Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 02 Sep 2026US$92.3bUS$48.3bUS$744.1m15.5x124.1x1.9x
Fri, 31 Jul 2026US$86.0bUS$47.9bUS$708.5m15.4x121.4x1.8x
Sun, 28 Jun 2026US$84.0bUS$48.3bUS$693.8m17.3x121.1x1.7x
Tue, 26 May 2026US$80.8bUS$48.4bUS$753.3m15.7x107.2x1.7x
Thu, 23 Apr 2026US$77.7bUS$48.1bUS$614.6m22.6x126.4x1.6x
Sat, 21 Mar 2026US$80.8bUS$48.2bUS$678.5m21.5x119.1x1.7x
Mon, 16 Feb 2026US$93.8bUS$48.0bUS$846.8m22.5x110.8x2x
Wed, 14 Jan 2026US$92.9bUS$47.6bUS$350.3m21.7x265.2x2x
Fri, 12 Dec 2025US$91.3bUS$47.6bUS$351.2m23.2x260x1.9x
Sun, 09 Nov 2025US$83.1bUS$47.5bUS$491.5m20.6x169.1x1.8x
Tue, 07 Oct 2025US$88.1bUS$47.7bUS$307.3m20.1x286.6x1.8x
Thu, 04 Sep 2025US$100.6bUS$47.6bUS$303.6m22.1x331.4x2.1x
Sat, 02 Aug 2025US$101.6bUS$48.1bUS$113.1m20.7x897.5x2.1x
Mon, 30 Jun 2025US$96.7bUS$48.0bUS$109.4m17.5x883.9x2x
Wed, 28 May 2025US$93.8bUS$48.0bUS$113.4m18.4x827.5x2x
Fri, 25 Apr 2025US$85.3bUS$48.7bUS$549.4m21.7x155.2x1.8x
Sun, 23 Mar 2025US$91.0bUS$48.7bUS$378.1m28.1x240.7x1.9x
Tue, 18 Feb 2025US$90.8bUS$49.0bUS$335.7m23.9x270.4x1.9x
Thu, 16 Jan 2025US$95.8bUS$49.3bUS$1.5b26.3x64.9x1.9x
Sat, 14 Dec 2024US$103.6bUS$49.3bUS$1.5b29.1x70.1x2.1x
Mon, 11 Nov 2024US$98.2bUS$49.3bUS$1.5b27.3x66.8x2x
Wed, 09 Oct 2024US$107.5bUS$49.5bUS$1.6b25.9x66.5x2.2x
Fri, 06 Sep 2024US$110.0bUS$49.5bUS$1.6b21x67.2x2.2x
Sun, 04 Aug 2024US$105.2bUS$48.9bUS$2.5b22.9x42.6x2.2x
Tue, 02 Jul 2024US$111.3bUS$49.0bUS$2.4b21.3x45.9x2.3x
Thu, 30 May 2024US$118.1bUS$49.0bUS$2.4b20.3x48.7x2.4x
Sat, 27 Apr 2024US$125.7bUS$48.8bUS$2.5b24.6x49.5x2.6x
Mon, 25 Mar 2024US$130.8bUS$48.8bUS$2.5b24.6x52.5x2.7x
Wed, 21 Feb 2024US$127.1bUS$49.2bUS$2.5b30.1x50.7x2.6x
Fri, 19 Jan 2024US$123.0bUS$50.1bUS$2.6b27.1x48.2x2.5x
Sun, 17 Dec 2023US$127.2bUS$49.9bUS$2.6b27.1x48.3x2.5x
Tue, 14 Nov 2023US$105.8bUS$49.9bUS$2.7b23.8x39.4x2.1x
Thu, 12 Oct 2023US$118.0bUS$50.0bUS$3.3b24.3x36x2.4x
Sat, 09 Sep 2023US$129.9bUS$50.0bUS$3.3b19.8x39.6x2.6x
Price to Earnings Ratio

39.6x


Total Market Cap: US$129.9bTotal Earnings: US$3.3bTotal Revenue: US$50.0bTotal Market Cap vs Earnings and Revenue0%0%0%
U.S. Personal Products Industry Price to Earnings3Y Average 177.9x202420252026
Current Industry PE
  • Investors are pessimistic on the American Personal Products industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 124x which is lower than its 3-year average PE of 178x.
  • The industry is trading close to its 3-year average PS ratio of 2.1x.
Past Earnings Growth
  • The earnings for companies in the Personal Products industry have declined 39% per year over the last three years.
  • Meanwhile revenues have remained mostly flat.
  • This means that although sales have remained flat, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the U.S. Consumer Staples industry?

US Market-0.92%
Consumer Staples-1.38%
Personal Products-3.16%
Personal Products-3.16%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
COTY CotyUS$2.846.4%
+US$149.7m		-34.6%PS0.4x
IPAR InterparfumsUS$117.110.5%
+US$17.6m		2.8%PE22.4x
HNST Honest CompanyUS$5.632.3%
+US$13.4m		46.6%PS1.8x
AXIL AXIL BrandsUS$7.0012.0%
+US$5.1m		32.3%PE17.7x
USNA USANA Health SciencesUS$13.961.3%
+US$3.3m		-55.9%PS0.3x

Latest News

HLF
US$11.52
Herbalife
7D
-10.8%
1Y
17.7%
EL
US$100.00
Estée Lauder Companies
7D
-4.6%
1Y
10.1%
EPC
US$27.94
Edgewell Personal Care
7D
-3.5%
1Y
17.8%
Seeking Alpha • 21h

Edgewell Personal Care Company's Turnaround Is Paying Off

Summary Edgewell Personal Care Company remains a "Buy" after a successful business transformation and significant debt reduction following the Feminine Care segment divestiture. EPC's valuation is compelling, trading at attractive multiples both absolutely and relative to peers, with only one comparable cheaper on key metrics. Recent results show modest revenue growth, mixed profitability, and temporary supply constraints in Wet Shave, but Sun & Skin Care delivered strong organic sales gains. Management guides to FY26 adjusted EPS of $1.80–$2.00, EBITDA of $250–$260 million, and operating cash flow of around $159.8 million. Read the full article on Seeking Alpha
GLAS
US$8.49
Glass House Brands
7D
-16.2%
1Y
6.8%
AXIL
US$7.00
AXIL Brands
7D
12.0%
1Y
32.3%
HNST
US$5.63
Honest Company
7D
2.3%
1Y
46.6%
YSG
US$2.66
Yatsen Holding
7D
-10.1%
1Y
-72.4%
KVUE
US$18.75
Kenvue
7D
-3.0%
1Y
-9.8%
Seeking Alpha • Aug 24

Kenvue: Acquisition By Kimberly-Clark Hit An Obstacle - What Now

Summary Kenvue Inc. is being acquired by Kimberly-Clark in a mixed cash-and-stock deal, offering KVUE holders $19.71 per share. China’s SAMR has initiated a phase 2 antitrust review, potentially delaying the merger but not necessarily blocking it. The deal’s value for KVUE holders is highly sensitive to KMB’s share price, introducing significant volatility and risk. KVUE stock trades near intrinsic value; holding until deal closure offers diversification, but exiting now is reasonable if you dislike the merger. Read the full article on Seeking Alpha
NUS
US$4.57
Nu Skin Enterprises
7D
-5.8%
1Y
-62.3%
SKIN
US$0.68
SkinHealth Systems
7D
3.8%
1Y
-66.3%
Narrative Update • Aug 21

SKIN: Future Returns Will Depend On Executing Reverse Split And FY26 EBITDA Targets

Analysts have trimmed their price target on SkinHealth Systems to $0.90 from $1.00 as they refresh models to reflect softer delivery system revenue and a lower future P/E multiple, while still acknowledging relatively steady consumables demand in a more competitive market. What’s in the News for SkinHealth Systems SkinHealth Systems has called a special meeting of stockholders for September 22, 2026 to vote on a reverse stock split proposal that would combine existing Class A common shares at a ratio between 1 for 5 and 1 for 20.
IPAR
US$117.11
Interparfums
7D
0.5%
1Y
2.8%
Narrative Update • Aug 21

IPAR: Asset Light Licensing And 2027 Runway Will Shape Fair 2026 Outlook

Interparfums' analyst fair value estimate has shifted from $109.33 to $126.67, as analysts balance higher modeled revenue growth and a richer future P/E of about 26.4x against tempered margin expectations and recent valuation driven rating downgrades across the Street. Analyst Commentary Recent Street research on Interparfums presents a split picture, with bullish analysts focusing on the company’s positioning in global fragrances and bearish analysts focusing on valuation and earnings risk into 2027.
COTY
US$2.84
Coty
7D
6.4%
1Y
-34.6%
Narrative Update • Aug 20

COTY: Gucci License Exit And Coty Curated Reset Will Support Future Earnings Power

Analysts have trimmed their fair value estimate for Coty from $6.70 to $3.72 as they balance stronger recent Q4 sales and a modestly lower discount rate with questions about the pace of revenue growth, the impact of the Gucci license exit, and mixed price target signals that now range from $2.60 to $3.00. Analyst Commentary on Coty Recent Street research on Coty highlights a split view.
USNA
US$13.96
USANA Health Sciences
7D
1.3%
1Y
-55.9%
BRBR
US$10.31
BellRing Brands
7D
-4.2%
1Y
-75.2%
Narrative Update • Aug 13

BRBR: Margin Headwinds And Governance Overhang Will Shape Recovery Expectations

BellRing Brands' fair value estimate has moved from $9.00 to $10.00 as analysts factor in higher price targets tied to strong demand across key product lines, tempered by recent margin pressures and updated long term profitability and P/E assumptions. Analyst Commentary Recent Street research on BellRing Brands points to a mixed setup, with several firms lifting price targets while also flagging clear execution and valuation risks.
CABR
US$1.35
Caring Brands
7D
5.1%
1Y
-61.4%
MTEX
US$7.15
Mannatech
7D
10.9%
1Y
-16.9%